Ironwood Pharmaceuticals, Inc. - Laporan Laba Rugi (TTM)

Ironwood Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US46333X1081

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Ironwood Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 399 390 398 413 413 414 422 416 421 411 417 427 432 443 414 401 378 351 318 309
Change (%) -2.41 2.29 3.66 0.07 0.11 2.10 -1.61 1.18 -2.36 1.59 2.43 1.19 2.39 -6.59 -3.14 -5.53 -7.14 -9.60 -2.88
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 112 91 76 67 56 70 66 65 66 5 46 55 76 6 19 30 27 8 9 2
Change (%) -18.27 -16.21 -12.97 -16.22 26.36 -6.62 -1.08 0.98 -92.48 837.80 17.98 38.89 -91.90 210.93 55.51 -9.95 -71.79 21.41 -76.51
% of Revenue 27.96 23.41 19.18 16.10 13.48 17.02 15.56 15.65 15.62 1.20 11.10 12.78 17.54 1.39 4.62 7.42 7.07 2.15 2.89 0.70
Gross Operating Profit 288 298 322 347 358 343 357 351 355 406 371 373 357 437 394 371 352 344 309 306
Change (%) 3.74 7.94 7.61 3.19 -3.98 3.89 -1.71 1.21 14.32 -8.58 0.49 -4.33 22.46 -9.65 -5.98 -5.17 -2.22 -10.28 -0.69
% of Revenue 72.04 76.59 80.82 83.90 86.52 82.98 84.44 84.35 84.38 98.80 88.90 87.22 82.46 98.61 95.38 92.58 92.93 97.85 97.11 99.30
SG&A 144 140 131 123 116 111 112 115 116 116 118 120 124 142 149 154 158 144 131 111
Change (%) -2.99 -6.71 -5.51 -5.82 -4.38 1.09 2.73 0.76 -0.26 1.94 1.23 3.20 15.04 4.57 3.62 2.38 -8.49 -9.25 -15.40
% of Revenue 36.16 35.94 32.78 29.88 28.12 26.86 26.59 27.77 27.65 28.25 28.35 28.02 28.57 32.10 35.93 38.44 41.66 41.06 41.21 35.90
R&D 39 99 99 99 99 104 104 104
Change (%) 0.00 0.00 0.00 5.30 0.00 0.00
% of Revenue 9.58 22.28 23.85 24.62 26.07 29.56 32.70 33.67
OpEx 256 231 207 190 172 182 178 180 182 160 165 174 199 247 266 282 283 256 244 217
Change (%) -9.65 -10.46 -8.26 -9.46 5.58 -1.90 1.33 0.84 -11.93 2.67 5.95 14.38 23.83 7.88 6.00 0.25 -9.67 -4.59 -11.14
% of Revenue 64.11 59.35 51.96 45.98 41.60 43.88 42.16 43.41 43.27 39.03 39.45 40.80 46.11 55.77 64.41 70.49 74.80 72.76 76.80 70.27
Operating Income 143 158 191 223 241 232 244 235 239 250 253 253 233 196 147 118 95 96 74 92
Change (%) 10.52 20.90 16.56 8.18 -3.79 5.23 -3.75 1.44 4.93 0.90 0.14 -7.89 -15.95 -24.84 -19.69 -19.33 0.37 -22.99 24.46
% of Revenue 35.89 40.65 48.04 54.02 58.40 56.12 57.84 56.59 56.73 60.97 60.55 59.20 53.89 44.23 35.59 29.51 25.20 27.24 23.20 29.73
Interest Expense -29 -29 -30 -30 -31 -31 -26 -20 -14 -8 -7 -6 -15 -21 -27 -33 -33 -33 -34 -35
Change (%) 1.37 1.38 1.39 1.39 1.40 -16.97 -21.36 -31.06 -45.82 -10.71 -5.41 129.58 45.12 26.68 21.70 -1.27 2.28 2.52 1.87
% of Revenue -7.29 -7.57 -7.50 -7.34 -7.43 -7.53 -6.12 -4.89 -3.33 -1.85 -1.63 -1.50 -3.41 -4.83 -6.55 -8.23 -8.60 -9.47 -10.74 -11.27
Net Income 111 106 143 509 530 528 527 173 168 175 182 -917 -952 -1,002 -1,052 9 -2 1 -32 -8
Change (%) -4.20 34.45 256.45 4.21 -0.35 -0.21 -67.17 -3.19 4.47 3.95 -604.07 3.82 5.25 4.98 -100.88 -126.74 -135.73 -3,775.45 -75.62
% of Revenue 27.77 27.26 35.83 123.20 128.30 127.72 124.83 41.65 39.85 42.64 43.63 -214.68 -220.24 -226.37 -254.41 2.30 -0.65 0.25 -10.18 -2.56

Source: Capital IQ

Other Listings
DE:I76 € 0.97
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista